Securing Gene Synthesis Act
- Introduced Jul 19
- Committee Jul 19
- Passed Senate Next
- Passed House Not yet
- To President Not yet
- Law Not yet
Companies lobbying on this bill
1 companyVotes
No recorded roll-call vote on this bill yet
Member trades
No member of Congress traded these companies in the last 90 days
Summary
Securing Gene Synthesis Act
Full summary1 paragraphs
This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.
Library of Congress summary, Jul 19, 2023
- Introduced in SenateJul 19, 2023
Actions
- SenateIntroduced in SenateJul 19, 2023
- SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.Jul 19, 2023
Bill record
Text versions1
- Introduced in SenateJul 19, 2023PDF: Introduced in Senate
Committees1
- Senate Health, Education, Labor, and Pensions CommitteeReferred To Jul 19, 2023
Sponsor and cosponsors0 cosponsors
- Sen. Edward Markey (D-MA)Sponsor, Jul 19, 2023
Amendments0
No amendments offered
Cost estimates and reports0
No cost estimate or committee report yet
Titles2
- Securing Gene Synthesis ActShort Title(s) as Introduced
- A bill to require the Secretary of Health and Human Services to prescribe a regulation reducing the risks in gene synthesis products, and for other purposes.Official Title as Introduced
Subjects9
Related bills1
- H.R. 4702 118th, Identical bill Securing Gene Synthesis Act
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.